Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL999 in metastatic renal cell carcinoma
NCT00277316Phase 2Terminated
- Sponsor
- Symphony Evolution
- Start
- Dec 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xl999 in renal cell carcinoma (RCC), sponsored by Symphony Evolution. Started Dec 2005; status: terminated.
02
Drugs
xl999
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00277316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277316.